The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer

Immunotherapy has led to a paradigm shift in the treatment of several cancers. There have been significant efforts to identify biomarkers that can predict response and toxicities related to immune checkpoint inhibitor (ICPI) therapy. Despite these advances, it has been challenging to tease out why a...

Descripción completa

Detalles Bibliográficos
Autores principales: Naqash, Abdul Rafeh, Kihn-Alarcón, Alba J., Stavraka, Chara, Kerrigan, Kathleen, Maleki Vareki, Saman, Pinato, David James, Puri, Sonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Cancer Immunotherapy: Recent Advances and Challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267312/
https://www.ncbi.nlm.nih.gov/pubmed/34277834
http://dx.doi.org/10.21037/atm-20-6427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267312/
https://www.ncbi.nlm.nih.gov/pubmed/34277834
http://dx.doi.org/10.21037/atm-20-6427

Ejemplares similares